Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed
Condition:   Polymyalgia Rheumatica Intervention:   Drug: Rituximab Sponsors:   Sint Maartenskliniek;   Dutch Arthritis Association;   ZonMw: The Netherlands Organisation for Health Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2022 Category: Research Source Type: clinical trials

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse
Condition:   Polymyalgia Rheumatica Intervention:   Drug: Rituximab Sponsors:   Sint Maartenskliniek;   ZonMw: The Netherlands Organisation for Health Research and Development;   Dutch Arthritis Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2022 Category: Research Source Type: clinical trials

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed
Condition:   Polymyalgia Rheumatica Intervention:   Drug: Rituximab Sponsors:   Sint Maartenskliniek;   Dutch Arthritis Association;   ZonMw: The Netherlands Organisation for Health Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2022 Category: Research Source Type: clinical trials

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse
Condition:   Polymyalgia Rheumatica Intervention:   Drug: Rituximab Sponsors:   Sint Maartenskliniek;   ZonMw: The Netherlands Organisation for Health Research and Development;   Dutch Arthritis Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2022 Category: Research Source Type: clinical trials

Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial
Condition:   Efficacy and Safety Interventions:   Drug: Rituximab combined with tacrolimus induction + rituximab maintenance;   Drug: Rituximab combined with tacrolimus induction + tacrolimus maintenance;   Drug: Glucocorticoid combined with cyclophosphamide induction + maintenance Sponsor:   RenJi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2022 Category: Research Source Type: clinical trials

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed
Condition:   Polymyalgia Rheumatica Intervention:   Drug: Rituximab Sponsors:   Sint Maartenskliniek;   Dutch Arthritis Association;   ZonMw: The Netherlands Organisation for Health Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2022 Category: Research Source Type: clinical trials

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse
Condition:   Polymyalgia Rheumatica Intervention:   Drug: Rituximab Sponsors:   Sint Maartenskliniek;   ZonMw: The Netherlands Organisation for Health Research and Development;   Dutch Arthritis Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2022 Category: Research Source Type: clinical trials

A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy
Condition:   Double Express Diffuse Large B-cell Lymphoma Intervention:   Drug: Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy Sponsor:   Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2022 Category: Research Source Type: clinical trials